JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141446

ALLM, calpain inhibitor

Be the first to review this product! Submit a review

|

(4 Publications)

MW 401.6 Da, Purity >95%. Achieve your results faster with highly validated, pure and trusted compounds.
1 Images
Chemical Structure - ALLM, calpain inhibitor (AB141446)
  • Chemical Structure

Lab

Chemical Structure - ALLM, calpain inhibitor (AB141446)

2D chemical structure image of ab141446, ALLM, calpain inhibitor

Key facts

Purity

>95%

Form

Solid

form

Molecular weight

401.6 Da

Molecular formula

C<sub>1</sub><sub>9</sub>H<sub>3</sub><sub>5</sub>N<sub>3</sub>O<sub>4</sub>S

PubChem

4331

Nature

Synthetic

Solubility

Soluble in DMSO to 50 mM

Soluble in ethanol to 50 mM

Biochemical name

Calpain inhibitor II

Canonical smiles

CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCSC)C=O)NC(=O)C

InChi

InChI=1S/C19H35N3O4S/c1-12(2)9-16(20-14(5)24)19(26)22-17(10-13(3)4)18(25)21-15(11-23)7-8-27-6/h11-13,15-17H,7-10H2,1-6H3,(H,20,24)(H,21,25)(H,22,26)

InChiKey

RJWLAIMXRBDUMH-UHFFFAOYSA-N

IUPAC Name

2-acetamido-4-methyl-N-[4-methyl-1-[(4-methylsulfanyl-1-oxobutan-2-yl)amino]-1-oxopentan-2-yl]pentanamide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1835 Calpain Inhibitor II, ALLM. 1835-25 is the same size as the 25 mg size of ab141446.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

PloS one 20:e0316822 PubMed39841661

2025

Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models.

Applications

Unspecified application

Species

Unspecified reactive species

Yixing Wu,Karen Cleverley,Frances K Wiseman

Acta neuropathologica communications 11:132 PubMed37580797

2023

Cathepsin B abundance, activity and microglial localisation in Alzheimer's disease-Down syndrome and early onset Alzheimer's disease; the role of elevated cystatin B.

Applications

Unspecified application

Species

Unspecified reactive species

Yixing Wu,Paige Mumford,Suzanna Noy,Karen Cleverley,Alicja Mrzyglod,Dinghao Luo,Floris van Dalen,Martijn Verdoes,Elizabeth M C Fisher,Frances K Wiseman

PloS one 16:e0242236 PubMed34292972

2021

The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Yixing Wu,Heather T Whittaker,Suzanna Noy,Karen Cleverley,Veronique Brault,Yann Herault,Elizabeth M C Fisher,Frances K Wiseman

Frontiers in cell and developmental biology 9:669086 PubMed34222239

2021

Junctional ER Organization Affects Mechanotransduction at Cadherin-Mediated Adhesions.

Applications

Unspecified application

Species

Unspecified reactive species

Michelle Joy-Immediato,Manuel J Ramirez,Mauricio Cerda,Yusuke Toyama,Andrea Ravasio,Pakorn Kanchanawong,Cristina Bertocchi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com